Health and Healthcare

24/7 Wall St. Biotech Report: Short-Selling And Splits (AMGN)(CELG)

Windmill_2_lgShort sellers moved out of biotech stocks in the latest period according to Biohealth Investor.

The short interest in Amgen (AMGN) dropped 22% and Calgene (CELG) fell 20%.

Alexion Pharmaceuticals (ALXN) split its shares 2-for-1 stock.

The company’s stock has done well as this was in the mid-$70’s in mid-July and shares put in a new 52-week and multi-year high this week with shares briefly trading above $95.00.

 

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.